Camden National vs National Bank
CAC and NBHC side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CAC and NBHC compare
National Bank is the larger company, worth 1.6 times as much as Camden National ($1.6B against $1.0B).
On earnings, Camden National is cheaper: it trades at 11.2× trailing earnings, against 15.6× for National Bank.
Camden National grew revenue faster over the last twelve months (9.0% versus 7.3% for National Bank).
Camden National keeps more of each dollar of sales as profit, with a net margin of 208% compared with 203% at National Bank.
Both pay dividends: Camden National yields 2.8% and National Bank 3.4%.
Camden National scores higher on the StockData Score (16 against 11 for National Bank), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CAC | NBHC |
|---|---|---|
| Size and price | ||
| Market cap | $1.0B | $1.6B |
| Share price | $59.31 | $37.04 |
| Change, 1 year | 51.2% | −0.48% |
| Change, 5 years | 23.6% | −18.1% |
| Beta (5Y) | 0.55 | 0.67 |
| Employees | 683 | 1,302 |
| StockData Score | ||
| Total score | 16 (better) | 11 |
| Valuation score | 1 | 2 (better) |
| Growth score | 1 (better) | 0 |
| Performance score | 5 (better) | 2 |
| Health score | 5 (better) | 4 |
| Dividend score | 4 (better) | 3 |
| Valuation | ||
| P/E | 11.2× (better) | 15.6× |
| P/S | 23.1× (better) | 34.0× |
| P/B | 1.4× | 1.0× (better) |
| P/FCF | 10.0× | – |
| PEG | – | 1.67 |
| FCF yield | 10.0% | – |
| Fair value | $56.27 | $37.80 |
| Margin of safety | −5.4% | 2.0% (better) |
| Growth | ||
| Revenue growth (TTM) | 9.0% (better) | 7.3% |
| Revenue growth, 5Y average | 8.5% (better) | 7.8% |
| Net income growth (TTM) | 57.7% (better) | −17.5% |
| EPS growth (TTM) | 51.3% (better) | −23.2% |
| EPS growth, 5Y average | −0.56% | 0.00% (better) |
| Profitability | ||
| Net margin | 208% (better) | 203% |
| FCF margin | 232% | – |
| Return on equity | 12.9% (better) | 6.5% |
| Financial health | ||
| Debt / equity | 0.43 | – |
| Altman Z-score | 0.22 (better) | 0.16 |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 2.8% | 3.4% (better) |
| Payout ratio | 31.6% | 53.3% |
| Years of dividend growth | 0 | 9 (better) |
| Dividend growth, 5Y average | 4.9% | 8.4% (better) |
| Buyback yield | 0.40% | 2.3% (better) |
| Shareholder yield | 3.2% | 5.7% (better) |
| Ownership | ||
| Held by institutions | 75.6% | 92.6% |
| Held by insiders | 2.6% | 8.4% |
| Insider net buying, 12 months | – | $812K |
| Short interest, % of float | 4.3% | 4.6% |
Go deeper
- CAC stock overview
- CAC income statement
- CAC valuation and score
- NBHC stock overview
- NBHC income statement
- NBHC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.